Posts Tagged ‘novavax’

FDA Flags Heart Inflammation Risk Over Novavax COVID-19 Vaccine

FDA staff on Friday flagged the risk of heart inflammation following the administration of the Novavax COVID-19 vaccine.  In the company’s nearly 30,000 patient trial, conducted between December 2020 and September 2021, there were four cases of myocarditis detected within 20 days post-vaccination, the Epoch Times reports.

After 33 Years of Failure to Produce Any Vaccine Novavax Targets Children for COVID-19 Vaccine

Original image Brian ShilhavyEditor, Health Impact NewsBen Adams of FiercePharma, the marketing trade publication for the pharmaceutical industry, just published an article today announcing that Novavax has unveiled a new “education campaign” for its COVID-19 vaccine that is expected to get an EUA (emergency use authorization) from the FDA soon.This “education campaign,” which I […]

Novavax: Soon to be FDA-Authorized COVID-19 Vaccine for the “Christian Pro-life” Population?

January 7, 2022 Print This Post Novavax: Soon to be FDA-Authorized COVID-19 Vaccine for the “Christian Pro-life” Population? by Brian ShilhavyEditor, Health Impact NewsIn July of 2020, when multiple pharmaceutical companies were competing for massive government funding to develop a “COVID-19 vaccine,” I published an article about one of the companies that had received massive amounts […]

Novavax Launches Trial for Combined Flu/COVID-19 Vaccine

A Maryland-based biotechnology company on Wednesday announced the launch of a clinical trial that will examine the efficacy and safety of a combined flu/COVID-19 vaccine. The early stage phase 1/2 study will examine a combination of a seasonal influenza vaccine candidate from Novavax and a COVID-19 vaccine candidate the company makes, neither of which have […]

Novavax Begins Trials For Its Combined Flu-Covid Vaccine

American vaccine-maker Novavax Inc said on Wednesday that it has launched an early stage trial of a vaccine which combines an as-yet-unapproved Covid-19 jab with the company’s NanoFlu influenza jab. The trial for the joint flu-Covid shot is being conducted in Australia. Novavax said it has initiated an early stage study, enrolling 640 healthy adults […]

Novavax COVID-19 vaccine 89% effective in UK trial, less in South Africa

Novavax Inc said on Thursday its coronavirus vaccine was 89.3% effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious variant first discovered in the UK, according to a preliminary analysis. A mid-stage trial of the vaccine in South Africa, where a troubling […]

Novavax COVID-19 vaccine appears 89% effective in UK study

A UK study for Novavax’s coronavirus vaccine shows it appears to be 89% effective, based on early findings. It also appears to work – but not quite as well – against the new strains of COVID-19 that were first found in England and South Africa. The announcement comes amid worries over whether the vaccines being […]

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes